# Surgiphor Us in TSA

> **NCT06601803** · PHASE4 · ENROLLING_BY_INVITATION · sponsor: **Rothman Institute Orthopaedics** · enrollment: 126 (estimated)

## Conditions studied

- Total Shoulder Arthroplasty
- Shoulder Infection
- Povidone Iodine

## Interventions

- **DRUG:** sterile saline solution
- **DRUG:** Surgiphor
- **PROCEDURE:** Sample Collection

## Key facts

- **NCT ID:** NCT06601803
- **Lead sponsor:** Rothman Institute Orthopaedics
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-09-16
- **Primary completion:** 2025-09-30
- **Final completion:** 2025-09-30
- **Target enrollment:** 126 (ESTIMATED)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06601803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06601803, "Surgiphor Us in TSA". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT06601803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*